ATC code N04
Talk0this wiki
Assessment |
Biopsychology |
Comparative |
Cognitive |
Developmental |
Language |
Individual differences |
Personality |
Philosophy |
Social |
Methods |
Statistics |
Clinical |
Educational |
Industrial |
Professional items |
World psychology |
Biological: Behavioural genetics · Evolutionary psychology · Neuroanatomy · Neurochemistry · Neuroendocrinology · Psychoneuroimmunology · Physiological Psychology · Psychopharmacology
| ATC codes |
|---|
| N Nervous system |
| N01 Anesthetics |
| N02 Analgesics |
| N03 Antiepileptics |
| N04 Anti-parkinson drugs |
| N05 Psycholeptics |
| N06 Psychoanaleptics |
| N07 Other nervous system drugs |
| ATCvet only |
| QN51 Products for animal euthanasia |
|
|
ATC code N04 Anti-parkinson drugs is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the [[World Health Organization|WHO]ATC code N03] for the classification of drugs and other medical products. Subgroup N04 is part of the anatomical group N Nervous system.[1]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: QN04...[2] </p>National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
Contents |
N04A Anticholinergic agents
N04AA Tertiary amines
- N04AA01 Trihexyphenidyl
- N04AA02 Biperiden
- N04AA03 Metixene
- N04AA04 Procyclidine
- N04AA05 Profenamine
- N04AA08 Dexetimide
- N04AA09 Phenglutarimide
- N04AA10 Mazaticol
- N04AA11 Bornaprine
- N04AA12 Tropatepine
N04AB Ethers chemically close to antihistamines
- N04AB01 Etanautine
- N04AB02 Orphenadrine (chloride)
N04AC Ethers of tropine or tropine derivatives
- N04AC01 Benzatropine
- N04AC30 Etybenzatropine
N04B Dopaminergic agents
N04BA Dopa and dopa derivatives
- N04BA01 Levodopa
- N04BA02 Levodopa and decarboxylase inhibitor
- N04BA03 Levodopa, decarboxylase inhibitor and COMT inhibitor
- N04BA04 Melevodopa
- N04BA05 Melevodopa and decarboxylase inhibitor
- N04BA06 Etilevodopa and decarboxylase inhibitor
N04BB Adamantane derivatives
- N04BB01 Amantadine
N04BC Dopamine agonists
- N04BC01 Bromocriptine
- N04BC02 Pergolide
- N04BC03 Dihydroergocryptine mesylate
- N04BC04 Ropinirole
- N04BC05 Pramipexole
- N04BC06 Cabergoline
- N04BC07 Apomorphine
- N04BC08 Piribedil
- N04BC09 Rotigotine
N04BD Monoamine oxidase B inhibitors
- N04BD01 Selegiline
- N04BD02 Rasagiline
N04BX Other dopaminergic agents
- N04BX01 Tolcapone
- N04BX02 Entacapone
- N04BX03 Budipine
References
- ↑ ATC/DDD Index Template:ATC codes lead/UpdateYear. WHO Collaborating Centre for Drug Statistics Methodology.
- ↑ ATCvet Index Template:ATC codes lead/UpdateYear vet. WHO Collaborating Centre for Drug Statistics Methodology.
Antiparkinson agents (N04) | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dopaminergics |
| ||||||||||||
| Anticholinergics |
Benzatropine • Biperiden# • Bornaprine • Chlorphenoxamine • Cyrimine • Dexetimide • Dimenhydrinate • Diphenhydramine • Etanautine • Etybenzatropine • Mazaticol • Metixene • Orphenadrine • Phenglutarimide • Piroheptine • Procyclidine • Profenamine • Trihexyphenidyl • Tropatepine | ||||||||||||
| Others | |||||||||||||
| Template:Central nervous system navs | |||||||||||||
Anti-parkinson drugs: dopaminergic agents (N04B) | |
|---|---|
| Dopa and derivatives | |
| Adamantane derivatives | |
| Dopamine agonists |
Apomorphine, Bromocriptine, Cabergoline, Dihydrexidine, Dihydroergocryptine mesylate, Fenoldopam, Lisuride, Pergolide, Piribedil, Pramipexole, Quinpirole, Ropinirole, Rotigotine, SKF 38393, SKF 82958 |
| MAOIs | |
| Other | |
| This page uses Creative Commons Licensed content from Wikipedia (view authors). |
